NYSE$AGL
agilon health inc. · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
agilon health reported a strong first quarter with significant revenue and membership growth, along with increased medical margin and adjusted EBITDA.
agilon health reported a 58% increase in revenue, driven by a 51% growth in Medicare Advantage membership. The company's medical margin increased by 66%, and net income was $1 million, a significant improvement from the previous year's net loss of $15 million.
- Total revenue increased by 58% to $653 million compared to Q1 2021.
- Total members on the agilon platform reached 342,000, including 250,000 Medicare Advantage members.
- Net income was $1 million, a significant improvement from the $15 million net loss in Q1 2021.
- Medical margin increased by 66% to $86 million.
Headline financials
Revenue & EPS history
agilon health · Revenue · Quarterly
$653M
Revenue by segment
agilon health · $653M total across 2 segments · Q1 2022
- Medical Services Revenue$652M+58.2%99.8%
- Other Operating Revenue$1.02M+47.7%0.2%
Forward guidance
Agilon health provided outlook for the second quarter and full year 2022, including expectations for Medicare Advantage members, Direct Contracting members, total members, total revenues, medical margin, and adjusted EBITDA.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2022
-2.6%
Avg return
Earnings day
-0.0%
Avg return
5 days after
+6.7%
Avg return
30 days after
50%
10 / 20 earnings
Positive
+20.2%
Q4 2025
Best reaction
-36.1%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | +122.0% | +256.9% | |
| Q4 2025 | +20.2% | +13.4% | -20.8% | |
| Q3 2025 | +5.1% | -9.0% | -9.9% | |
| Q1 2025 | -25.6% | -33.4% | -51.6% | |
| Q4 2024 | -7.4% | -17.9% | +23.7% | |
| Q3 2024 | -36.1% | -35.1% | -24.7% | |
| Q2 2024 | -12.7% | -14.6% | -36.8% | |
| Q1 2024 | +7.5% | +7.5% | +40.8% | |
| Q4 2023 | +3.1% | -2.1% | -1.1% | |
| Q3 2023 | -13.1% | -19.0% | -33.1% | |
| Q2 2023 | +0.7% | +3.7% | -7.9% | |
| Q1 2023 | -3.4% | -6.6% | -18.9% | |
| Q4 2022 | +15.4% | +14.8% | +12.0% | |
| Q3 2022 | -12.7% | -7.9% | -8.6% | |
| Q2 2022 | -3.3% | -0.4% | -20.3% | |
| Q1 2022 | -8.6% | -19.4% | +1.3% | |
| Q4 2021 | +10.6% | +2.4% | +31.7% | |
| Q3 2021 | +2.7% | +3.6% | -9.5% | |
| Q2 2021 | -3.8% | -6.3% | -3.4% | |
| Q1 2021 | +6.3% | +4.0% | +14.0% | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro